NCT01323140View on ClinicalTrials.gov

Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Hypogonadism
Interventions
DRUG

testosterone matrix transdermal system

Trial Locations (2)

Unknown

Watson Investigational Site, Fort Meyers

Watson Investigational Site, Tacoma

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT01323140 - Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems | Biotech Hunter | Biotech Hunter